Crescent Pharma

Crescent Pharma Limited is committed to ensuring the manufacture of medicinal products to the highest quality, safety and efficacy by adhering to, and implementing quality systems in compliance with GMP and GDP. Crescent Pharma is focused on increasing the intellectual property and product portfolio to a range of 400 generic, new combination and branded products by 2020. Crescent Pharma Limited, formed in 2003 is a fast growing, medium sized, privately owned UK Company. Crescent focused on a European and UK production strategy, currently manufactures approximately 150 generic and branded products and is committed to the continual development and growth in the portfolio aiming to offer a wider and diverse range of medicines to the supply chain. Delivering over 65 million packs in 2016, Crescent is now exporting to over 16 territories globally although remaining primarily focused on the UK market with offices and a warehouse distribution network including depots in London, the South and North England. Despite substantial recent growth in all areas of the organisation, Crescent continues to demonstrate the same quality culture and Small Business values that it has been founded on to give all stakeholders the best possible experience when working with Crescent. Crescent Pharma also owns a sister company, Crescent Pharma OTC formerly Anglian Pharmaceuticals, which focuses on the distribution and development of over the counter medicines, medical devices and CE marked products in the UK.